Literature DB >> 24717568

Survivorship: pain version 1.2014.

Crystal S Denlinger, Jennifer A Ligibel, Madhuri Are, K Scott Baker, Wendy Demark-Wahnefried, Debra L Friedman, Mindy Goldman, Lee Jones, Allison King, Grace H Ku, Elizabeth Kvale, Terry S Langbaum, Kristin Leonardi-Warren, Mary S McCabe, Michelle Melisko, Jose G Montoya, Kathi Mooney, Mary Ann Morgan, Javid J Moslehi, Tracey O'Connor, Linda Overholser, Electra D Paskett, Muhammad Raza, Karen L Syrjala, Susan G Urba, Mark T Wakabayashi, Phyllis Zee, Nicole McMillian, Deborah Freedman-Cass.   

Abstract

Many posttreatment cancer survivors experience chronic pain, often leading to psychological distress; decreased activity, motivation, and personal interactions; and an overall poor quality of life. This section of the NCCN Guidelines for Survivorship provides screening and management recommendations for pain in survivors. A multidisciplinary approach is recommended, with a combination of pharmacologic treatments, psychosocial and behavioral interventions, physical therapy and exercise, and interventional procedures.

Entities:  

Mesh:

Year:  2014        PMID: 24717568      PMCID: PMC4465256          DOI: 10.6004/jnccn.2014.0054

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN: 1540-1405            Impact factor:   11.908


  66 in total

1.  Topical (S)-ketamine for pain management of postherpetic neuralgia.

Authors:  Guilherme Antonio Moreira de Barros; Hélio Amante Miot; Ademir Massarico Braz; Flávia Ramos; Marcos Aristoteles Borges
Journal:  An Bras Dermatol       Date:  2012 May-Jun       Impact factor: 1.896

Review 2.  The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects.

Authors:  Joost L M Jongen; Mark L Huijsman; Jairo Jessurun; Kennedy Ogenio; David Schipper; Daan R C Verkouteren; Peter W Moorman; Carin C D van der Rijt; Kris C Vissers
Journal:  J Pain Symptom Manage       Date:  2013-02-12       Impact factor: 3.612

Review 3.  Classification of cancer pain syndromes.

Authors:  A Caraceni; S M Weinstein
Journal:  Oncology (Williston Park)       Date:  2001-12       Impact factor: 2.990

Review 4.  Exercise interventions on health-related quality of life for cancer survivors.

Authors:  Shiraz I Mishra; Roberta W Scherer; Paula M Geigle; Debra R Berlanstein; Ozlem Topaloglu; Carolyn C Gotay; Claire Snyder
Journal:  Cochrane Database Syst Rev       Date:  2012-08-15

Review 5.  Interventional therapies for the management of cancer pain.

Authors:  Shane Brogan; Scott Junkins
Journal:  J Support Oncol       Date:  2010 Mar-Apr

Review 6.  Prevalence of pain in patients with cancer: a systematic review of the past 40 years.

Authors:  M H J van den Beuken-van Everdingen; J M de Rijke; A G Kessels; H C Schouten; M van Kleef; J Patijn
Journal:  Ann Oncol       Date:  2007-03-12       Impact factor: 32.976

Review 7.  Psychological approaches to understanding and treating disease-related pain.

Authors:  Francis J Keefe; Amy P Abernethy; Lisa C Campbell
Journal:  Annu Rev Psychol       Date:  2005       Impact factor: 24.137

8.  Topical 2% amitriptyline and 1% ketamine in neuropathic pain syndromes: a randomized, double-blind, placebo-controlled trial.

Authors:  Mary E Lynch; Alexander J Clark; Jana Sawynok; Michael J L Sullivan
Journal:  Anesthesiology       Date:  2005-07       Impact factor: 7.892

Review 9.  The efficacy of psychosocial intervention for pain in breast cancer patients and survivors: a systematic review and meta-analysis.

Authors:  M Johannsen; I Farver; N Beck; R Zachariae
Journal:  Breast Cancer Res Treat       Date:  2013-04-04       Impact factor: 4.872

10.  Barriers to pain assessment and management in cancer survivorship.

Authors:  Virginia Sun; Tami Borneman; Barbara Piper; Marianna Koczywas; Betty Ferrell
Journal:  J Cancer Surviv       Date:  2008-02-15       Impact factor: 4.442

View more
  7 in total

1.  Severe functional limitation due to pain & emotional distress and subsequent receipt of prescription medications among older adults with cancer.

Authors:  Carolyn J Presley; Maureen Canavan; Shi-Yi Wang; Shelli L Feder; Jennifer Kapo; Maureen L Saphire; Ella Sheinfeld; Erin E Kent; Amy J Davidoff
Journal:  J Geriatr Oncol       Date:  2020-03-10       Impact factor: 3.599

2.  Pain in older survivors of hematologic malignancies after blood or marrow transplantation: A BMTSS report.

Authors:  Naveed Farrukh; Lindsey Hageman; Yanjun Chen; Jessica Wu; Emily Ness; Michelle Kung; Liton Francisco; Mariel Parman; Wendy Landier; Mukta Arora; Saro Armenian; Smita Bhatia; Grant R Williams
Journal:  Cancer       Date:  2020-02-05       Impact factor: 6.860

3.  Patterns of pain medication use associated with reported pain interference in older adults with and without cancer.

Authors:  Amy J Davidoff; Maureen E Canavan; Shelli Feder; Shiyi Wang; Ella Sheinfeld; Erin E Kent; Jennifer Kapo; Carolyn J Presley
Journal:  Support Care Cancer       Date:  2019-10-21       Impact factor: 3.603

4.  Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?

Authors:  Laura Micheli; Elena Lucarini; Francesca Corti; Roberto Ciccocioppo; Girolamo Calò; Anna Rizzi; Carla Ghelardini; Lorenzo Di Cesare Mannelli
Journal:  Eur J Pharmacol       Date:  2018-01-31       Impact factor: 4.432

5.  The efficacy of a technology-based information and coaching/support program on pain and symptoms in Asian American survivors of breast cancer.

Authors:  Eun-Ok Im; Sangmi Kim; You Lee Yang; Wonshik Chee
Journal:  Cancer       Date:  2019-11-12       Impact factor: 6.860

Review 6.  Intrathecal Therapy for Cancer-Related Pain.

Authors:  Brian M Bruel; Allen W Burton
Journal:  Pain Med       Date:  2016-04-28       Impact factor: 3.750

7.  Methodological quality of clinical practice guidelines with physical activity recommendations for people diagnosed with cancer: A systematic critical appraisal using the AGREE II tool.

Authors:  Shirin M Shallwani; Judy King; Roanne Thomas; Odette Thevenot; Gino De Angelis; Ala' S Aburub; Lucie Brosseau
Journal:  PLoS One       Date:  2019-04-10       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.